ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

Size: px
Start display at page:

Download "ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section."

Transcription

1 2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section COMPRITOL 888 Non proprietary names BP: Glycerol Dibehenate Ph Eur: Glycerol Dibehenate USP-NF: Glyceryl Behenate Synonyms Glyceryl Behenate; 2,3-dihydroxypropyl docosanoate; docosanoic acid, 2,3- dihydroxypropyl ester; E471; glycerol behenate; glyceroli dibehenas; glyceryl monobehenate. Chemical name and CAS registry number Docosanoic acid, monoester with glycerin [ ] (glyceryl behenate) Docosanoic acid, diester with glycerin [ ] (glyceryl dibehenate) Docosanoic acid, triester with glycerin [ ] (glyceryl tribehenate) Description Compritol 888 occurs as a fine white-yellow powder, as a hard waxy mass or pellet, or as white or almost white unctuous flakes with faint odor. Empirical formula and molecular weight Glyceryl dibehenate is a mixture of glycerol esters. The PhEur 6.0 describes glyceryl dibehenate as a mixture of diacylglycerols, mainly dibehenoylglycerol, together with variable quantities of mono- and triacylglycerols. The USP32 NF27 describes glyceryl behenate as a mixture of glycerides of fatty acids, mainly behenic acid. It specifies that the content of 1-monoglycerides should be %. 189

2 Structural Formula Functional category Coating agent, tablet binder Tablet and capsule lubricant Thickening agent Viscosity increasing agent Physical properties HLB value = 2 Melting point = C Solubility = Soluble, when heated, in chloroform and dichloromethane and in many organic solvents; slightly soluble in hot ethanol (96%); practically insoluble in cold ethanol (95%), hexane, mineral oil, and water. Stability and storage conditions Glyceryl behenate should be stored in a tightly closed container, at a temperature less than 35 o C. Safety Glyceryl behenate is used in cosmetics, foods and oral pharmaceutical formulations, and is generally regarded as a relatively non irritant and nontoxic material. The US Cosmetic Ingredients Review Expert Panel evaluated glyceryl behenate and concluded that it is safe for use in cosmetic formulations in present practices of use and concentration. LD50 (mouse, oral): 5 g/kg. Applications in pharmaceutical formulation or technology In pharmaceutical formulations, glyceryl behenate is mainly used as a lubricant in the preparation of oral tablets and capsules. It has good binding properties, it does not 190

3 affect tablet hardness and is unaffected by mixing or production parameters. Glyceryl behenate has been investigated for the encapsulation of various drugs such as retinoids. It has also been investigated for use in the preparation of sustained-release tablets; as a matrix-forming agent for the controlled release of water-soluble drugs and it can also be used as a hot-melt coating agent sprayed onto a powder or drugloaded sugar beads and granules. It may also be incorporated via extrusion/spheronization into pellets, which can be further compressed into tablets. Glyceryl behenate is used in oral enteric coated pellets, powders and suspensions. It is also used in controlled, extended release and orally disintegrating tablets. For oral preparations, glyceryl behenate forms a lipidic matrix for sustained-release formulations GELUCIRE 43/01 Gelucire are a family of vehicles derived from mixtures of mono-, di- and triglycerides with polyethylene glycol esters of fatty acids. Gelucire 43/01 describes as a gelucire having melting point of 43 o C having HLB value of 1. Chemical name and CAS registry number Semi-synthetic glycerides made of saturated C 8 -C 18 fatty acid glycerides [ ]. Description Gelucire is light white waxy solid having light odor except atomized gelucire 70/02 is available as powders Functional category Low HLB gelucire are used as hydrophobic matrix carrier while high HLB gelucire are utilized for enhancement of solubility and dissolution of poorly water-soluble drug. Gelucire 70/02 called as Compritol 888 ATO is also used as lubricant. Structural formula C 12 -C 18 mono-, di- and triglycerides 191

4 Physical properties Melting point: 42 to 45 o C Flash point: 150 O C Solubility: Insoluble in water, freely soluble in chloroform and methylene chloride and slightly soluble in ethanol. Stability and storage conditions Prevent exposure to air, heat and moisture and store in its original non opened packing. Applications in pharmaceutical formulation or technology Gelucire are a family of vehicles derived from mixtures of mono-, di- and triglycerides with polyethylene glycol esters of fatty acids. Lipids are considered as an alternative to polymer in the design of sustained drug delivery systems due to their advantages such as the low melt viscosity (thus avoiding the need of organic solvents for solubilization), absence of toxic impurities such as residual monomer catalysts and initiators, potential biocompatibility and biodegradability. Gelucire are available with a range of properties depending on their Hydrophilic Lipophilic Balance (HLB 1-18) and melting point (33-70 o C) range. Gelucire 43/01 is used as excipient for hard gelatin capsules especially for drug protection against oxidation and hydrolysis. Gelucire 43/01 is also used for handling of low density products or toxic or low dose drugs. Gelucire 43/01 is also utilized for solid dosage form having liquid drugs. Gelucire 70/02 which is called as Compritol 888 available in powder form is used as lubricant at low concentration and used as binder in hot melt extrusion above 10 % as at this concentration it is used as hydrophobic matrices. The Gelucires containing only PEG esters (Gelucire 55/18) are generally used in preparation of fast release formulations, while Gelucires containing only glycerides or a mixture of glycerides and PEG esters (Gelucire 54/02, 50/13, 43/01) are used in preparation of sustained release formulations HYDROXYPROPYL METHYL CELLULOSE (HPMC) 192

5 Hydroxypropyl methyl cellulose (HPMC) is mixed hydroxyl alkyl cellulose ether and may be regarded as the propylene glycol ether of methyl cellulose. It is available in many grades of different viscosity range from 5 cps to cps. Non-proprietary names BP: Hypromellose JP: Hydroxypropyl methylcellulose USP: Hypromellose Chemical name and CAS registry number Cellulose, 2-hydroxypropyl methyl ether [ ] Description Odorless, tasteless, white or creamy white fibrous or granular powder Empirical formula and molecular weight The PhEur 2002 describes hypromellose as a partly O-methylated and O-(2- hydroxypropylated) cellulose. Grades may be distinguished by appending a number indicative of the apparent viscosity, in mpa s, of a 2% w/w aqueous solution at 20 C. Hypromellose defined in the USP 26 specifies the substitution type by appending a four-digit number to the nonproprietary name: e.g., hypromellose The first two digits refer to the approximate percentage content of the methoxy group (OCH 3 ). The second two digits refer to the approximate percentage content of the hydroxypropoxy group [OCH 2 CH (OH) CH 3 ], calculated on a dried basis. Molecular weight is approximately Structural formula Viscosity (2% aqueous solution) 193

6 HPMC K100 LV: 100 cps HPMC K4M: 4000 cps HPMC K15M: cps HPMC K100M: cps Functional category Coating agent Film-former Rate-controlling polymer for sustained release Stabilizing agent Suspending agent Tablet binder Viscosity-increasing agent Physical properties Acidity/alkalinity: ph = for a 1% w/w aqueous solution. Ash: %, depending upon the grade Auto ignition temperature: 360 C Density (bulk): g/cm 3 Density (tapped): g/cm 3 Density (true): g/cm 3 Melting point: browns at C; chars at C Glass transition temperature is C Specific gravity: 1.26 Solubility Soluble in cold water, forming a viscous colloidal solution; practically insoluble in chloroform, ethanol (95%), and ether, but soluble in mixtures of ethanol and dichloromethane, mixtures of methanol and dichloromethane, and mixtures of water and alcohol. Certain grades of hypromellose are soluble in aqueous acetone solutions, mixtures of dichloromethane and propan-2-ol, and other organic solvents. Moisture content 194

7 Hypromellose absorbs moisture from the atmosphere, the amount of water absorbed depending upon the initial moisture content and the temperature and relative humidity of the surrounding air. Stability and storage conditions Hypromellose powder is a stable material, although it is hygroscopic after drying. Solutions are stable at ph Increasing temperature reduces the viscosity of solutions. Hypromellose undergoes a reversible sol gel transformation upon heating and cooling, respectively. The gel point is C, depending upon the grade and concentration of material. Aqueous solutions are comparatively enzyme-resistant, providing good viscosity stability during long term storage. However, aqueous solutions are liable to microbial spoilage and should be preserved with an antimicrobial preservative: when hypromellose is used as a viscosity-increasing agent in ophthalmic solutions, benzalkonium chloride is commonly used as the preservative. Aqueous solutions may also be sterilized by autoclaving; the coagulated polymer must be redispersed on cooling by shaking. Hypromellose powder should be stored in a well-closed container, in a cool, dry place. Incompatibilities Hypromellose is incompatible with some oxidizing agents. Since it is non ionic, hypromellose will not complex with metallic salts or ionic organics to form insoluble precipitates. Safety Hypromellose is widely used as an excipient in oral and topical pharmaceutical formulations. It is also used extensively in cosmetics and food products. Hypromellose is generally regarded as a nontoxic and non irritant material, although excessive oral consumption may have a laxative effect. The WHO has not specified an acceptable daily intake for hypromellose since the levels consumed were not considered to represent a hazard to health. LD50 (mouse, IP): 5 g/kg LD50 (rat, IP): 5.2 g/kg Applications in pharmaceutical formulation or technology 195

8 It is suspending, viscosity enhancing and film forming agent. HPMC is most widely used in hydrophilic matrix sustaining release tablets and other type of controlled release pharmaceutical dosage forms, because of its characteristic namely non-toxic nature, its capacity to incorporate active pharmaceutical, manufacture of tablet by direct compression without previous granulation as well as ph independent nature POLY VINYL PYRROLIDONE (PVP) Non-proprietary names BP: Povidone JP: Povidone PhEur: Povidonum USP: Povidone Synonyms E1201; Kollidon; Plasdone; poly[1-(2-oxo-1-pyrrolidinyl)ethylene]; polyvidone; polyvinylpyrrolidone; PVP; 1-vinyl-2-pyrrolidinone polymer. Chemical name and CAS registry number -Ethenyl-2-pyrrolidinone homopolymer [ ] Description Povidone occurs as a fine, white to creamy-white coloured, odourless or almost odourless, hygroscopic powder. Empirical formula and molecular weight (C 6 H 9 NO)n ,00,000 The USP 28 describes povidone as a synthetic polymer consisting essentially of linear 1-vinyl-2-pyrrolidinone groups, the differing degree of polymerization of which results in polymers of various molecular weights. It is characterized by its viscosity in aqueous solution, relative to that of water, expressed as a K-value, in the range Structural Formula 196

9 Functional category Disintegrant Dissolution aid Suspending agent Tablet binder. Table I uses of povidone Use Concentration (%) Carrier for drugs Dispersing agent Up to 5 Eye drops 2-10 Suspending agent Up to 5 Tablet binder, tablet diluents, or coating agent Physical Properties Acidity/alkalinity: ph = (5% w/v aqueous solution). Density (bulk): g/cm 3 for Plasdone. Density (tapped): g/cm 3 for Plasdone. Density (true): g/cm 3 Flowability: 20 g/s for povidone K-15; 16 g/s for povidone K-29/32. Melting point: softens at 150 ºC. Moisture content: povidone is very hygroscopic, significant amounts of moisture being absorbed at low relative humidity. Particle size distribution: Kollidon 25/30: 90 % >50 mm, 50 % >100 mm. Solubility: freely soluble in acids, chloroform, ethanol (95 %), ketones, methanol, and water; practically insoluble in ether, hydrocarbons, and mineral 197

10 oil. In water, the concentration of a solution is limited only by the viscosity of the resulting solution, which is a function of the K-value. Stability and storage conditions Povidone darkens to some extent on heating at 1508 ºC, with a reduction in aqueous solubility. It is stable to a short cycle of heat exposure around ºC; steam sterilization of an aqueous solution does not alter its properties. Aqueous solutions are susceptible to mold growth and consequently require the addition of suitable preservatives. However, since the powder is hygroscopic, it should be stored in an airtight container in a cool, dry place. Applications in pharmaceutical formulation or technology Although povidone is used in a variety of pharmaceutical formulations, it is primarily used in solid-dosage forms. In tableting, povidone solutions are used as binders in wet- granulation processes. Povidone is used as a solubilizer in oral and parenteral formulations and has been shown to enhance dissolution of poorly soluble drugs from solid-dosage forms. Povidone solutions may also be used as coating agents. Povidone is additionally used as a suspending, stabilizing, or viscosity-increasing agent in a number of topical and oral suspensions and solutions 198

METOLOSE: CONTENTS PAGE

METOLOSE: CONTENTS PAGE METOLOSE: CONTENTS PAGE 2 Preface What is Metolose Substitution types Specifications 1) Available grades & viscosity 2) Nomenclature 3) Packaging Characteristics of Metolose Properties of Metolose 1) Powder

More information

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1 1. INTRODUCTION 1.1. Sustained Drug delivey: 1-6 It is defined as any drug or dosage form modification that prolongs the therapeutic activity of the drug. The amount of drug in the body decrease slowly

More information

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information

More information

CHAPTER-2 DRUG AND POLYMER PROFILES

CHAPTER-2 DRUG AND POLYMER PROFILES 57 CHAPTER-2 DRUG AND POLYMER PROFILES 58 2.1 DRUG PROFILES 2.1.1 Lamivudine (3TC) 85 US FDA approval date: November 1995 Structural formula of lamivudine Physicochemical properties of lamivudine 1. Description

More information

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019

More information

Granulation Aggregation

Granulation Aggregation Granulation Aggregation Wet granulation Solvent granulation (crust granules) Binder granulation (sticked granules) Granulation liquid Water Water + alcohol mixture Macromolecular colloidal solution i.e.:

More information

Polyoxyethylene 20 Sorbitan mono oleate, [ ] Colour and Physical form at 25 C: Yellow oily liquid

Polyoxyethylene 20 Sorbitan mono oleate, [ ] Colour and Physical form at 25 C: Yellow oily liquid 5. EXCIPIENT PROFILE 5.1 Polysorbate 80: [68] Nonproprietary Name BP: Polysorbate80 JP: Polysorbate80 Ph Eur: Polysorbate80 USP-NF: Polysorbate80 Synonym: Capmul POE-O; CremophorPS80; Crillet4; polyoxyethylene

More information

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Critical material properties for the design of robust drug products : excipient functionality related characteristics Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition

More information

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ QbD Approach to Formulation of Hydrophilic Matrix Using Sample Kit of Hypromellose [Metolose SR] DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa,

More information

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Paradigm shift in pharmaceutical development Traditional medicinal products

More information

Functional Excipients for Suppository Applications

Functional Excipients for Suppository Applications Functional Excipients for Suppository Applications Skin Delivery Platform 2016 1 The Skin Delivery Platform Major areas of activity are in 4 pillars PLATFORM : SKIN DELIVERY Dermal Drug Delivery Mildness

More information

Industrial Pharmacy (3) Solutions as a dosage form. DR.Saad.M.YACOUB

Industrial Pharmacy (3) Solutions as a dosage form. DR.Saad.M.YACOUB Industrial Pharmacy (3) Solutions as a dosage form DR.Saad.M.YACOUB Solutions: definition A solution is a homogenous one-phase system consisting of two or more components. The solvent, or mixture of solvents,

More information

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and

More information

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM

More information

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository

More information

AnyCoat. From Nature, Beside you.

AnyCoat. From Nature, Beside you. AnyCoat From Nature, Beside you www.lotte-cellulose.com 04 AnyCoat is 05 Certificates of AnyCoat AnyCoat-C 06 General Characteristics 07 Specifications 08 Chemical Structure, Nomenclature 09 Functional

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating

More information

Hydroxypropyl Starch (Tentative)

Hydroxypropyl Starch (Tentative) Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016 Hydroxypropyl Starch (Tentative) This monograph was also published in: Compendium

More information

Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy

Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy Suppositories are solid dosage forms intended for insertion into body orifices where they melt, soften, or dissolve

More information

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar

More information

Chapter 3 LITERATURE REVIEW

Chapter 3 LITERATURE REVIEW 21 Chapter 3 LITERATURE REVIEW 22 3.0. LITERATURE REVIEW The most preliminary step for the initiation of Research work is the collection of Literature and it gives a full background of various technologies

More information

Oleochemistry. Oleochemical derivatives

Oleochemistry. Oleochemical derivatives Oleochemistry by Shamsul Bin Zakaria Faculty Industrial Science and Technology shamsulzakaria@ump.edu.my The students should be able to understand: Oleochemical reactions and their applications Five basic

More information

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same

More information

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives 2.1 Introduction According to the Food Protection Committee of the Food and Nutrition Board, food additives

More information

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry:

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry: 13. SUPPOSITORY They are solid single-dose preparations whose shapes, volumes and consistencies are suitable for rectal administration. There are also such vaginal preparations in the treatment of local

More information

Parenteral products-definition

Parenteral products-definition Parenteral products-definition Parenteral preparations are sterile, pyrogen-free liquids (solutions, emulsions, or suspensions) or solid dosage forms packaged in either single-dose or multidose containers.

More information

Emulsions. Purpose of emulsions and of emulsification:

Emulsions. Purpose of emulsions and of emulsification: Pharmacist Ghada Hamid Emulsions Emulsion is a dispersion in which the dispersed phase is composed of small globules of a liquid distributed throughout a vehicle in which it is immiscible. The dispersed

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical

More information

1. NOMENCLATURE : 2,4-Hexadienoic Acid. : Hexadienoic acid. : 1,3- Pentadiene 1- Carboxylic Acid.

1. NOMENCLATURE : 2,4-Hexadienoic Acid. : Hexadienoic acid. : 1,3- Pentadiene 1- Carboxylic Acid. Chemical Preservatives (Approved by FSSAI) 1. Sorbic Acid (FCC IX) / E-200 2. Potassium Sorbate (FCC IX) / E-202) 3. D-Hydro Acetic Acid (DHA) (FCC IV) (E-265) 4. Sodium D-hydro Acetic Acid (E-266) FINESHED

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1 US 2003.01.18647A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0118647 A1 Seth (43) Pub. Date: (54) EXTENDED RELEASE TABLET OF Publication Classification METFORMIN (51)

More information

EUDRAGIT L 100 and EUDRAGIT S 100

EUDRAGIT L 100 and EUDRAGIT S 100 Technical Information EUDRAGIT L 100 and EUDRAGIT S 100 Specification and Test Methods Ph. Eur. Methacrylic Acid - Methyl Methacrylate Copolymer (1:1) Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)

More information

EUDRAGIT E 100, EUDRAGIT E PO and

EUDRAGIT E 100, EUDRAGIT E PO and Technical Information EUDRAGIT E 100, and Specification and Test Methods Ph. Eur. USP/NF JPE Basic Butylated Methacrylate Copolymer Amino Methacrylate Copolymer - NF Aminoalkyl Methacrylate Copolymer E

More information

LAB.2. Tablet Production Methods

LAB.2. Tablet Production Methods LAB.2 Tablet Production Methods Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling

More information

Large scale production

Large scale production Large scale production Rotary capsule machine: This machine has two, side-by-side cylinders in each of which half-moulds are cut. These cylinders, like the rollers of a mangle, rotate in contrary direction

More information

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium. BRIEFING Croscarmellose Sodium, NF 22 page 2856 and page 702 of PF 30(2) [Mar. Apr. 2004]. A modification is made in the test for Degree of substitution to correct the endpoint color to agree with the

More information

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Dow Wolff Cellulosics Pharmaceutical Excipients Using ingenuity and savvy to help design healthcare solutions TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Enhancing

More information

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.

More information

1. Identification of the Substance and of the Company :

1. Identification of the Substance and of the Company : 1. Identification of the Substance and of the Company : Product Description : Pharma Glycerine 99.5 % Product Code No : 501254 Synonyms : E 422 1,2,3 Propanetriol Glycerol Trihydroxypropane Intended Uses

More information

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS. BROMOPHOS 4-bromo-2,5-dichloropheny1 dimethy1 phosphorothioate

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS. BROMOPHOS 4-bromo-2,5-dichloropheny1 dimethy1 phosphorothioate AGP: CP/70 FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS BROMOPHOS 4-bromo-2,5-dichloropheny1 dimethy1 phosphorothioate FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1977 DISCLAIMER

More information

REVISION OF MONOGRAPH ON TABLETS. Tablets

REVISION OF MONOGRAPH ON TABLETS. Tablets March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016 Continuous Granulation Using a Twin-Screw Extruder Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016 What is a twin screw extruder and how to use it for continuous granulation? Dry feed:

More information

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING Dr. Dieter Lubda MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany Agenda: Sustained release

More information

CAPMUL + CAPTEX + ACCONON = SEDDS

CAPMUL + CAPTEX + ACCONON = SEDDS OUR SOLUTIONS PORTFOLIO ABITEC products are specifically designed for meeting the solubility challenges of the pharmaceutical industry. Our products can be used alone or in conjunction with one another

More information

slight, characteristic colour Gardner max. 4

slight, characteristic colour Gardner max. 4 Castor oil CAS No. 8001-79-4 Castor oil (also known as Ricinus oil) is a vegetable oil extracted by mechanical pressing of the Castor seed. It is pale-yellowish or almost colorless with a mild characteristic

More information

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box 84-1 FROM SOLVENT TO AQUEOUS COATINGS (Out of the Frying Pan...) Ralph E. Pondell Coating Place, Inc. P.O. Box 930310 Verona, WI 53593 A number of reasons exist for the current high level of interest in

More information

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY DRY SYRUPS SEMINAR BY SWAPNA.M M.PHARMACY Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL CONTENTS DEFINITION CHARACTERISTICS OF SUSPENSIONS

More information

FATTY-ACID CAPPED OLIGOMERIC PROPANEDIOL SUCCINATES

FATTY-ACID CAPPED OLIGOMERIC PROPANEDIOL SUCCINATES FATTY-ACID CAPPED OLIGOMERIC PROPANEDIOL SUCCINATES Note: This research was presented at the 2016 in cosmetics exhibition in Paris on April 13, 2016. Purpose: Successfully produced propanediol succinates

More information

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007) November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications

More information

The Function of Emollients in Skin Care

The Function of Emollients in Skin Care The Function of Emollients in Skin Care Benjamin Schwartz Ontario SCC Education Day September 18, 2018 Lipid knowledge for the personal care industry Emollient - definition Wikipedia: complex mixtures

More information

TABLET DESIGN AND FORMULATION

TABLET DESIGN AND FORMULATION TABLET DESIGN AND FORMULATION PART 5 Industrial pharmacy 5th class 1st semester TABLET DESIGN AND FORMULATION Conventional oral tablets for ingestion usually contain the same classes of components in addition

More information

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS Prepared at the 39th JECFA (1992), published in FNP 52 Add 1 (1992). Metals and arsenic specifications revised at

More information

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of

More information

SWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin

SWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin SWEETINDIA Following Synthetic Sweeteners available on regular basis. Acesulfame Potassium Aspartame Sucralose Sodium Cyclamate Sodium Saccharin FINISHED PRODUCT INFORMATION Product: Acesulfame Potassium

More information

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical Excipient Quality & Trouble Shooting By Seema Trivedi GM, Technical Back Ground The Society for Pharmaceutical Dissolution Science (SPDS) had held its 6th Annual International Convention Disso India -

More information

COMMISSION DIRECTIVE 2010/67/EU

COMMISSION DIRECTIVE 2010/67/EU 21.10.2010 Official Journal of the European Union L 277/17 DIRECTIVES COMMISSION DIRECTIVE 2010/67/EU of 20 October 2010 amending Directive 2008/84/EC laying down specific purity criteria on food additives

More information

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples Professor Jiasheng Tu, Ph. D. France 2018/09 content 1 Introduction 2 PESS guidance

More information

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability Andreas Gryczke, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

AGP: CP/89 FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS. PHENTHOATE S - a - ethoxycarbonylbenzyl 00-dimethyl phosphorodithioate

AGP: CP/89 FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS. PHENTHOATE S - a - ethoxycarbonylbenzyl 00-dimethyl phosphorodithioate AGP: CP/89 FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS PHENTHOATE S - a - ethoxycarbonylbenzyl 00-dimethyl phosphorodithioate FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 1980 DISCLAIMER

More information

EXCIPIENTS. EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA. IOI Oleo GmbH

EXCIPIENTS. EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA. IOI Oleo GmbH EXCIPIENTS EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs IOI Oleo GmbH PHARMA Contents EXCIPIENTS... 5 Liquid lipids... 6 Solid triglycerides... 8 Partial glycerides... 12 Emulsifiers... 14 Specialties...

More information

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group FORMULATION CHOICE How and why they are chosen Dr Andy Fowles On behalf of ECPA Specification Expert Group Topics Why formulate? How to identify formulation options Drivers Principle formulation type overview

More information

(Non-legislative acts) REGULATIONS

(Non-legislative acts) REGULATIONS 29.8.2013 Official Journal of the European Union L 230/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) No 816/2013 of 28 August 2013 amending Annex II to Regulation (EC) No 1333/2008

More information

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY Excipients are inactive ingredients used as carriers for the active ingredients in a pharmaceutical product. These may

More information

KURARAY POVAL & EXCEVAL

KURARAY POVAL & EXCEVAL Characteristics Polyvinyl alcohol (PVOH) having varying degree of polymerization and. Recommended Uses Ranging from emulsion polymerization aid to binder for pigments in paper applications. Form supplied

More information

UNISHAPES MACROSCOPIC PELLETS OF DIFFERENT FORMS AND COLORS FOR COSMETIC PRODUCTS

UNISHAPES MACROSCOPIC PELLETS OF DIFFERENT FORMS AND COLORS FOR COSMETIC PRODUCTS MACROSCOPIC PELLETS OF DIFFERENT FORMS AND COLORS FOR COSMETIC PRODUCTS Characterization Unishapes are dry pellets in different forms that consist of Mannitol and micro-crystalline Cellulose. They are

More information

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION (19) (11) EP 1 864 677 B1 (12) EUROPEAN PATENT SPECIFICATION (4) Date of publication and mention of the grant of the patent: 02.01.08 Bulletin 08/01 (1) Int Cl.: A61K 38/ (06.01) A61K 9/ (06.01) A61K 31/39

More information

TABLET COATING 2. Lec. 9

TABLET COATING 2. Lec. 9 TABLET COATING 2 Lec. 9 Development of film coating formulations The development of film coating formulations depend on the following: 1. Purpose of coating (either masking taste, odor or color, or control

More information

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39 (19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 233 131 A1 (43) Date of publication: 29.09. Bulletin /39 (1) Int Cl.: A61K 9/ (06.01) A61K 31/00 (06.01) (21) Application number: 09908.8 (22) Date of filing:

More information

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*

More information

STARCH Application Data

STARCH Application Data STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone

More information

2.3 EXCIPIENTS REVIEW: STARCH 119 : Excipients Review

2.3 EXCIPIENTS REVIEW: STARCH 119 : Excipients Review 2.3 EXCIPIENTS REVIEW: 2.3.1 STARCH 119 : Nonproprietary Name: B.P.: Potato starch Ph. Eur: solani amylum USP NF: Starch Functional category: Glidant, tablet and capsule diluent & disintegrant, tablet

More information

Name the ester produced when methanol and pentanoic acid react. methyl pentanoate. Name the type of reaction used to make an ester

Name the ester produced when methanol and pentanoic acid react. methyl pentanoate. Name the type of reaction used to make an ester 1 Name the ester produced when methanol and pentanoic acid react methyl pentanoate 2 Name the type of reaction used to make an ester condensation reaction 3 Name the by-product of the reaction used to

More information

PRODUCT CODE BC VERSION NUMBER SPECIFICATION

PRODUCT CODE BC VERSION NUMBER SPECIFICATION 1. SPECIFICATION Product Description: β-carotene powder 10% TAB is a red or red-brown powder, with white spots of food starch.manufactured by spray drying adopting the advanced microencapsulation technology.

More information

EXCIPIENTS. EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA. IOI Oleo GmbH

EXCIPIENTS. EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA. IOI Oleo GmbH EXCIPIENTS EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA IOI Oleo GmbH Contents EXCIPIENTS... 5 Liquid lipids... 6 Solid triglycerides... 8 Partial glycerides... 12 Emulsifiers... 14 Specialities...

More information

Cholesterin, Cholesterine, Cholesteryl alcohol, Dythol, Provitamin D. PRODUCT CAS NUMBER % BY WEIGHT Cholesterol %

Cholesterin, Cholesterine, Cholesteryl alcohol, Dythol, Provitamin D. PRODUCT CAS NUMBER % BY WEIGHT Cholesterol % Section 1 Company Information Parchem - fine & specialty chemicals 415 Huguenot Street New Rochelle, NY 10801 (914) 654-6800 (914) 654-6899 parchem.com info@parchem.com EMERGENCY RESPONSE NUMBER: CHEMTEL

More information

The binding performance of DFE Pharma Starch

The binding performance of DFE Pharma Starch The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients

More information

MIGLYOL Gel B, Gel T, 840 Gel B

MIGLYOL Gel B, Gel T, 840 Gel B MIGLYOL Gel B, Gel T, 840 Gel B INCI: Gel B: Caprylic/Capric Triglyceride, Stearalkonium Hectorite, Propylene Carbonate Gel T: Caprylic/Capric Triglyceride, Stearalkonium Bentonite, Propylene Carbonate

More information

Suppository Chapter Content

Suppository Chapter Content 10 min SUPPOSITORY Suppository Chapter Content 1. Suppositories and Factors Affecting Drug Absorption 2. Ideal Suppository and Different Types of Bases 3. Methods of Suppository Manufacturing Suppository

More information

B. semisolid materials consisting of hydrophilic and hydrophobic portions

B. semisolid materials consisting of hydrophilic and hydrophobic portions CHEM 470 Understanding Emulsions I. Definitions A. Any heterogeneous system which has at least one immiscible or barely miscible liquid dispersed in another liquid in the form of tiny droplets. A. Becher,

More information

AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES

AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES AMENDMENTS TO THE SECOND REVISION OF THE FIRST EDITION OF THE MANUAL ON DEVELOPMENT AND USE OF FAO AND WHO SPECIFICATIONS FOR PESTICIDES Page Current text Revised text Notes P.21 A. 10.1. WHO classification

More information

Eastman cellulose esters Pharmaceutical applications and drug delivery

Eastman cellulose esters Pharmaceutical applications and drug delivery Eastman cellulose esters Pharmaceutical applications and drug delivery Cellulose esters are part of a large family of cellulose derivatives that have a long history of use in pharmaceutical applications.

More information

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010,

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010, Development and Evaluation of a Directly Compressible Co-processed Multifunction Sustained Release Agent for Gliclazide Sustained Release Tablets J. Ayyappan* 1, P.Umapathi 1, Darlin Quine 2 1 Department

More information

Defoaming Surfactants

Defoaming Surfactants Defoaming Surfactants Surfadol -series DDTM-based surfactants Addinova High quality alternatives 1 Agenda 1. Introduction 2. Drop-ins 3. Generic Product Properties 4. Product List and Specific Features

More information

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS International Journal of PharmTech Research CODEN( USA): IJPRIF ISSN : 0974-4304 Vol.1, No.3, pp 634-638, July-Sept 2009 FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS K. Reeta Vijaya

More information

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries. Technical Information Kolliwax HCO September 2015 03_150617e_00/Page 1 of 8 WF-No. 129938 = Registered trademark in many countries Hydrogenated castor oil powder for pharmaceutical use 03_150617e_00 September

More information

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose 1 Pharmaceutical industry borrowed ingredients from other industries Food Cosmetic Industrial Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work that has all changed

More information

Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD

Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD INTRODUCTION Drug solubilization has drawn attention in recent years because

More information

Cremophor RH 40. Technical Information. For the pharmaceuticals industry

Cremophor RH 40. Technical Information. For the pharmaceuticals industry Technical Information Cremophor RH 40 ME 069 e (262) August 1997 (MPM) Register 5 = Registered trademark of BASF Aktiengesellschaft For the pharmaceuticals industry Cremophor RH 40 is a solubilizer for

More information

SCIENTIFIC DISCUSSION. Lopinavir and Ritonavir 200 mg/50 mg Tablets * Name of the Finished Pharmaceutical Product:

SCIENTIFIC DISCUSSION. Lopinavir and Ritonavir 200 mg/50 mg Tablets * Name of the Finished Pharmaceutical Product: SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:

More information

EXCIPIENTS FOR PHARMACEUTICALS

EXCIPIENTS FOR PHARMACEUTICALS EXCIPIENTS FOR PHARMACEUTICALS SCOPE OF APPLICATION IOI Oleo GmbH PHARMA Contents Regulatory background for the IOI Oleo site in Witten: Regulatory background for the IOI Oleo site in Witten... 3 Injectables

More information

Non-Food Uses of Polysaccharides

Non-Food Uses of Polysaccharides Non-Food Uses of Polysaccharides John Mitchell John.Mitchell@biopolymersolutions.co.uk Acknowledgements Fundamentals of Hydrocolloid Technology Course (2003-2009) Rob Winwood Colin Melia Steve Harding

More information

Challenges and solutions for moisture sensitive API formulation

Challenges and solutions for moisture sensitive API formulation Challenges and solutions for moisture sensitive API formulation Introduction Today, formulators are looking for alternative processes to reformulate existing products or to formulate New Chemical Entities

More information

FATS & OILS GLOSSARY

FATS & OILS GLOSSARY FATS & OILS GLOSSARY Antioxidant A substance that slows or interferes with the reaction of a fat or oil with oxygen. The addition of antioxidants to fats or foods containing them retard rancidity and increases

More information

SOFT GELATIN CAPSULE. Dr. Nawal Ayash

SOFT GELATIN CAPSULE. Dr. Nawal Ayash SOFT GELATIN CAPSULE Dr. Nawal Ayash 1 Soft gelatin capsule DEFINITION:- soft Gelatin capsules are one piece, hermetically sealed, soft gelatin shells containing a liquid, a suspension, or a semisolid.

More information

02/09/2016. Roles of Excipients in Pharmaceuticals:

02/09/2016. Roles of Excipients in Pharmaceuticals: Definition: Any substance other than the active drug or prodrug that is included in the manufacturing process or is contained in a finished pharmaceutical dosage form. Excipients are not inactive and have

More information

Care Chemicals & Formulators. Emulan types. Technical Information. = Registered trademark of BASF group Emulan A Emulan OC. Emulan AT 9 Emulan OP 25

Care Chemicals & Formulators. Emulan types. Technical Information. = Registered trademark of BASF group Emulan A Emulan OC. Emulan AT 9 Emulan OP 25 Technical Information Emulan types August 2010 Supersedes issue dated December 2009 08_0806138e-01/Page 1 of 12 = Registered trademark of BASF group Emulan A Emulan OC Emulan A Special Emulan OC Solution

More information

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam

More information

Kolliphor P Grades. Technical Information. Poloxamers for Pharmaceutical Use. = Registered trademark of BASF Poloxamers Ph. Eur.

Kolliphor P Grades. Technical Information. Poloxamers for Pharmaceutical Use. = Registered trademark of BASF Poloxamers Ph. Eur. Technical Information Kolliphor P Grades June 2013 Supersedes issue dated February 2013 03_111136e-03/Page 1 of 8 WF-No. 122937 = Registered trademark of BASF Poloxamers Ph. Eur., Poloxamer USP/NF Poloxamers

More information

Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell

Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell Comparison - Aqueous vs. Solvent based Ethylcellulose Films 80-2 by H.S. Hall, K.D. Lillie & R.E. Pondell Ethylcellulose has a long history of use in the pharmaceutical for coating pharmaceuticals in various

More information

Etat des travaux du GDP

Etat des travaux du GDP Etat des travaux du GDP (Avril 2018) Item General methods relevant to Q6A Dissolution (rev. 3) 4 Disintegration (rev. 1) 4 Uniformity of content/mass (rev. 2, corr. 1) 4 Tests for specified microorganisms

More information